147 related articles for article (PubMed ID: 36802170)
41. Exploring site-specific activation of bis-N,N'-dialkylaminophosphordiamidites and the synthesis of morpholinophosphoramidate oligonucleotides.
Krishna H; Jastrzebska K; Caruthers M
FEBS Lett; 2019 Jul; 593(13):1459-1467. PubMed ID: 31206627
[TBL] [Abstract][Full Text] [Related]
42. Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.
Swenson DL; Warfield KL; Warren TK; Lovejoy C; Hassinger JN; Ruthel G; Blouch RE; Moulton HM; Weller DD; Iversen PL; Bavari S
Antimicrob Agents Chemother; 2009 May; 53(5):2089-99. PubMed ID: 19223614
[TBL] [Abstract][Full Text] [Related]
43. Systemic and ICV Injections of Antisense Oligos into SMA Mice and Evaluation.
Aslesh T; Maruyama R; Yokota T
Methods Mol Biol; 2018; 1828():455-465. PubMed ID: 30171559
[TBL] [Abstract][Full Text] [Related]
44. In Vitro Delivery of PMOs in Myoblasts by Electroporation.
Goossens R; Aartsma-Rus A
Methods Mol Biol; 2022; 2434():191-205. PubMed ID: 35213018
[TBL] [Abstract][Full Text] [Related]
45. Advanced morpholino oligomers: a novel approach to antiviral therapy.
Warren TK; Shurtleff AC; Bavari S
Antiviral Res; 2012 Apr; 94(1):80-8. PubMed ID: 22353544
[TBL] [Abstract][Full Text] [Related]
46. Solid-phase chemical synthesis of 5'-triphosphate DNA, RNA, and chemically modified oligonucleotides.
Zlatev I; Manoharan M; Vasseur JJ; Morvan F
Curr Protoc Nucleic Acid Chem; 2012 Sep; Chapter 1():Unit1.28. PubMed ID: 22956453
[TBL] [Abstract][Full Text] [Related]
47. Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD.
Akpulat U; Wang H; Becker K; Contreras A; Partridge TA; Novak JS; Cirak S
Mol Ther Nucleic Acids; 2018 Dec; 13():534-542. PubMed ID: 30396145
[TBL] [Abstract][Full Text] [Related]
48. Toxicological Characterization of Exon Skipping Phosphorodiamidate Morpholino Oligomers (PMOs) in Non-human Primates.
Carver MP; Charleston JS; Shanks C; Zhang J; Mense M; Sharma AK; Kaur H; Sazani P
J Neuromuscul Dis; 2016 Aug; 3(3):381-393. PubMed ID: 27854228
[TBL] [Abstract][Full Text] [Related]
49. Oligodeoxynucleotides containing 2'-amino-LNA nucleotides as constrained morpholino phosphoramidate and phosphorodiamidate monomers.
Vejlegaard K; Paul S; Kosbar T; Wengel J; Caruthers MH
Bioorg Med Chem Lett; 2017 Jul; 27(14):3173-3176. PubMed ID: 28552336
[TBL] [Abstract][Full Text] [Related]
50. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy.
Maruyama R; Echigoya Y; Caluseriu O; Aoki Y; Takeda S; Yokota T
Methods Mol Biol; 2017; 1565():201-213. PubMed ID: 28364245
[TBL] [Abstract][Full Text] [Related]
51. Internal Oligoguanidinium Transporter: Mercury-Free Scalable Synthesis, Improvement of Cellular Localization, Endosomal Escape, Mitochondrial Localization, and Conjugation with Antisense Morpholino for NANOG Inhibition to Induce Chemosensitization of Taxol in MCF-7 Cells.
Kundu J; Banerjee P; Bose C; Das U; Ghosh U; Sinha S
Bioconjug Chem; 2020 Oct; 31(10):2367-2382. PubMed ID: 32986398
[TBL] [Abstract][Full Text] [Related]
52. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
Maruyama R; Aoki Y; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
[TBL] [Abstract][Full Text] [Related]
53. Solid-Phase Synthesis of RNA 5'-Azides and Their Application for Labeling, Ligation, and Cyclization Via Click Chemistry.
Warminski M; Kowalska J; Jemielity J
Curr Protoc Nucleic Acid Chem; 2020 Sep; 82(1):e112. PubMed ID: 32716612
[TBL] [Abstract][Full Text] [Related]
54. Chimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacy.
Fadzen CM; Holden RL; Wolfe JM; Choo ZN; Schissel CK; Yao M; Hanson GJ; Pentelute BL
Biochemistry; 2019 Sep; 58(38):3980-3989. PubMed ID: 31450889
[TBL] [Abstract][Full Text] [Related]
55. A Bioreductive Protecting Group for RNA Synthesis.
Saneyoshi H; Nakamura K; Terasawa K; Ono A
Curr Protoc; 2021 Sep; 1(9):e240. PubMed ID: 34499818
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and Purification of N
Mathivanan J; Du J; Mao S; Zheng YY; Sheng J
Curr Protoc; 2021 Nov; 1(11):e307. PubMed ID: 34792865
[TBL] [Abstract][Full Text] [Related]
57. Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
Wang M; Wu B; Tucker JD; Lu P; Lu Q
Int J Nanomedicine; 2015; 10():5635-46. PubMed ID: 26366082
[TBL] [Abstract][Full Text] [Related]
58. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
Mende F; Beisswenger M; Seitz O
J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
[TBL] [Abstract][Full Text] [Related]
59. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
Echigoya Y; Lim KRQ; Melo D; Bao B; Trieu N; Mizobe Y; Maruyama R; Mamchaoui K; Tanihata J; Aoki Y; Takeda S; Mouly V; Duddy W; Yokota T
Mol Ther; 2019 Nov; 27(11):2005-2017. PubMed ID: 31416775
[TBL] [Abstract][Full Text] [Related]
60. End-Modifications on Morpholino Oligos.
Li YF
Methods Mol Biol; 2017; 1565():39-50. PubMed ID: 28364232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
